Tubular expression of KIM-1 does not predict delayed function after transplantation

Area of Science:

• Nephrology
• Transplantation immunology
• Biomarker discovery

Background:

• Kidney Injury Molecule 1 (KIM-1) is upregulated in injured proximal tubule epithelial cells.
• KIM-1 is a potential biomarker for early kidney allograft injury.
• The role of KIM-1 in kidney allografts experiencing delayed graft function (DGF) is not well understood.

Purpose of the Study:

• To investigate KIM-1 expression in preperfusion kidney allograft biopsies.
• To correlate KIM-1 expression with DGF and clinical outcomes.
• To assess KIM-1's utility as a predictor of DGF.

Main Methods:

• Prospective measurement of KIM-1 RNA and protein expression in preperfusion biopsies.
• Analysis of 30 living-donor and 85 deceased-donor kidneys.
• Correlation of KIM-1 levels with histologic findings and clinical outcomes post-transplantation.

Main Results:

• KIM-1 expression was detected in 62% of deceased-donor kidneys versus 13% of living-donor kidneys (P < 0.0001).
• Pre-reperfusion KIM-1 levels correlated inversely with renal function at procurement and directly with interstitial fibrosis.
• No significant correlation was found between KIM-1 staining intensity and the incidence of DGF.

Conclusions:

• KIM-1 serves as an early indicator of tubular injury in kidney allografts.
• Pre-transplant tissue KIM-1 measurement is not supported as a method to identify kidneys at risk for DGF.
• Further research may explore other biomarkers for DGF prediction.